Clinical trials are commonly described as Phase I, II, III and IV, but the phases are better understood as different stages of evidence gathering.
Early trials often focus heavily on safety, tolerability and dosing. Later studies generally involve larger populations and place greater emphasis on whether an intervention produces the intended clinical benefit.
After approval, additional evidence may continue to emerge through post-marketing studies and real-world use.
The phase number therefore provides useful context, but it does not by itself tell readers whether a treatment is effective, appropriate or established.